Andrea Scheinker

Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy.

Part of Match Group, Inc., SK Holdings, Inc. is a company based in New York, NY.

Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC.

Gauss Surgical, Inc. engages in mobile health operation which specializes in blood and hemoglobin loss monitoring during surgery. Its services include research and development, publications, clinical performance, feature extraction technology, rapid integration with surgical workflow, and inoperative mobile platform. The company was founded by Siddarth Satish in 2011 and is headquartered in Los Altos, CA.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Part of Thermo Fisher Scientific, Inc., PPD Discovery is a company that provides integrated-product-development services for pharmaceutical and biotechnology. The company is based in Wilmington, NC.

Part of 1105 Media, Inc., Fawcette Technical Publications, Inc. publishes magazines and produces websites for the Information Technology community. The company is based in San Mateo, CA. Fawcette Technical Publications was acquired by 1105 Media, Inc. on January 02, 2007.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Apposite Capital LLP (Apposite Capital) is a private equity arm of Mizuho Financial Group, Inc. founded in 2016 by David Porter. The firm is headquartered in London, United Kingdom.

Genentech Ventures (Genentech Ventures) is a venture capital firm founded in 1900. The firm is headquartered in South San Francisco, CA.

Malaysian Life Sciences Capital Fund Management Co Ltd (MLSCFM) is a venture capital firm founded in 2006. The firm is headquartered in Kuala Lumpur, Malaysia.

NewBridge Pharmaceuticals FZ LLC engages in the manufacture and distribution of pharmaceutical products, therapeutics and medical devices. The company was founded by G. Garrett Vygantas in 2007 and is headquartered in Dubai, United Arab Emirates.

Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden.

Jump Capital LLC (Jump Capital) is a venture capital firm founded in 2012 by Mike B. McMahon and Sach Chitnis. The firm is headquartered in Chicago.

Visibly, Inc. develops a platform to perform an online eye exam. It operates as a healthcare technology firm that offers the convenient and affordable way to get a prescription for glasses and contacts. The firm’s technology provides valid glasses and contact lens prescriptions online from the convenience of home. The company was founded by Aaron Dallek and Steven Lee in 2012 and is headquartered in Chicago, IL.

MD Revolution, Inc. engages in the provision of a digital care management platform. Its product platform include care management features, clinical tools, patient engagement tools, and integration. The firm solutions also include Chronic Care Management; Remote Patient Monitoring; Behavioral Health Integration; Annual Wellness Visits; Transitional Care Management; Whole Person Care; Clinical Care Teams; And Care Program Design. The company was founded by Samir Damani in 2011 and is headquartered in Solana Beach, CA.

Korea Evaluation Institute of Industrial Technology operates as a research institute to develop technology for domestic industries. The company is based in Daegu, South Korea. The South Korean company is ultimately controlled by the Government of South Korea.

I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China.

Pieces Technologies, Inc. develops healthcare software solutions. Its products include pieces IRIS and pieces decision support. The company was founded by Ruben Amarasingham in 2007 and is headquartered in Dallas, TX.

OSF Ventures (OSF Ventures) is a venture capital subsidiary of OSF Healthcare System founded in 2016. The firm is headquartered in Illinois, Chicago.

Level Ex, Inc. engages in the provision of medical video games for physicians. It offers Cardio Ex, Pulm Ex, Gastro Ex, and Airway Ex games. The company was founded by Sam Z. Glassenberg in 2015 and is headquartered in Chicago, IL.

CBC Group (Singapore) Pte. Ltd.(CBC Group) is a private equity firm founded in 2014 by Wei Fu. The firm is headquartered in Singapore with additional offices in New York, Hong Kong, Shanghai and Beijing and is wholly owned by CBC Group Investment Management Ltd.

Global Genes is a non-profit organization that connects, empowers, and inspires the rare disease community to become more effective on their own behalf. The non-profit company is based in Aliso Viejo, CA and has subsidiaries in the United States. The company serve more than 400 million people around the globe and nearly one in 10 Americans affected by rare diseases. The organization helps spur innovation, meet essential needs, build capacity and knowledge, and drive progress within and across rare diseases. Global Genes was founded in 2008 and the CEO is Craig Martin.

HealthBridge Financial, Inc. provides health insurance services. It offers design, underwriting and servicing of credit solutions. The company is headquartered in Grand Rapids, MI.

Inflammatix, Inc. operates molecular diagnostics company which develops rapid tests that read the immune system. The firm specializes in molecular diagnostics, biotechnology, computational immunology, in-vitro diagnostics, personalized medicine and bioinformatics. The company was founded by Purvesh Khatri, Jonathan Romanowsky and Timothy Sweeney and is headquartered in Burlingame, CA.

Corsair Pharma, Inc. is a development stage biotechnology company. It focuses on the development of novel prodrugs of treprostinil to treat patients with pulmonary arterial hypertension using a once-daily transdermal patch. The company is headquartered in South San Francisco, CA.

PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan.

AffaMed Therapeutics is a Chinese company focused on providing innovative treatments to patients. The company is based in Shanghai, CN. The company's mission and vision are centered around improving patient access to these treatments. The company has a pipeline of products in development to achieve this goal. and has subsidiaries in United States and Hong Kong. The CEO of the company is Dayao Zhao.

TherOptix, Inc. develops and manufactures drug-eluting contact lens. The company is headquartered in San Francisco, CA.

Health Scholars, Inc. engages as a cloud-based, VR-ready training platform for the management, delivery, and analysis of clinical training. Its solutions include virtual reality training, and simulation management. The company was founded by Brian Gillett in 2017 and is headquartered in Westminster, CO.

InxMed Biotechnology Nanjing Co., Ltd. is a clinical-stage biotech company established in 2018, dedicated to developing innovative therapies to overcome treatment resistance, especially anti PD-1/PD-L1 resistance. InxMed is based in Nanjing, China, and has teams located in Shanghai and Beijing, with hubs in San Francisco and Melbourne. The Chinese company's innovations are inspired by patients and driven by in-depth understanding of disease biology and pharmacology. InxMed has raised tens of millions of US dollars in series A round financing and has an integrated high-caliber research and clinical development team across China, the US, and Australia. The company has built a unique innovative pipeline through its own discovery research and development and collaborative research and development. The company was founded in 2018 by Fei Cao and Zai Qi Wang, with Zai Qi Wang serving as the CEO since then.

KeifeRx LLC is a clinical-stage biopharmaceutical company that develops novel and optimized tyrosine kinase inhibitors (TKIs) for the treatment of neurodegenerative and immune diseases. KeifeRx is based in McLean, VA, and was founded in 2019 by Charbel Moussa and Fernando Pagan. The company's clinical pipeline is led by Nilotinib BE, an optimized, lower dose formulation of Nilotinib, which is currently in a multicenter phase 3 clinical trial for early Alzheimer's disease. KeifeRx's TKI portfolio includes an optimized oral dose of Bosutinib and Gutinib, which are undergoing clinical trials in Lewy body dementia and optimizing and IND enabling studies, respectively. The company's technologies are designed to treat neurodegenerative diseases and an array of inflammatory diseases where there are significant unmet clinical needs and limited therapeutic options. Chris Hoyt has been the CEO of the company since 2021.

Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023.

Riverine Ventures is a venture capital firm founded in 2022 by Garrett Vygantas. The firm is headquartered in Sausalito, California.